Results 201 to 210 of about 10,168 (235)

Special issue: advances in immunology and its applications. [PDF]

Acta Biochim Biophys Sin (Shanghai)
Han M, Wang H.
europepmc   +1 more source

Pancancer Fine‐Mapping of Mutational Intolerance Identifies CHEK1 as an Immunosuppressive Driver in Lung Adenocarcinoma

Advanced Science, EarlyView.
This study identifies mutation‐intolerant genes (MIGs), which are mutationally constrained in tumors despite normal‐tissue variability. Using miDriver, the authors pinpoint MIGs essential for tumor‐intrinsic fitness and immune evasion. Focusing on CHEK1, they show it drives tumor fitness and sculpts an immunosuppressive niche via the MIF–CD74 axis ...
Tao Wang, Hongyu Zhao, Xiaojie Sun, Yuqi Ding, Zhipeng Zhu, Xiaotong Yu, Rongyi Zhu, Dan Wang, Kailong Li, Yang Liu, Li‐Bin Wang, Xiaolu Zhao, Baojun Suo, Hongsen Bi, Peipei Zhang, Tong Liu, Fengbiao Mao   +16 more
wiley   +1 more source

Subacute cutaneous lupus erythematosus secondary to intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy: A case report. [PDF]

JAAD Case Rep
Smith K, Nathoo R, Foss MG.
europepmc   +1 more source

The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis. [PDF]

Target Oncol
Tokunaga K, Fujiwara Y, Omori R, Sato T, Ahluwalia MS, Mukherjee S.   +5 more
europepmc   +1 more source

Pharmacovigilance Insights Into Immune Checkpoint Inhibitor-Induced Risk of Paraneoplastic Syndrome: A Large-Scale Real World Study. [PDF]

CNS Neurosci Ther
Tang B, Song X, Sun Y, Wan J, Hu W, Ma Y, Lin Y, Zhang J, Wang Y, Feng H, Luo P, Guo D, Qu X.   +12 more
europepmc   +1 more source

The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective. [PDF]

Clin Cancer Res
López-Botet M, Vilches C, Muntasell A.
europepmc   +1 more source

Takotsubo Syndrome Triggered by Immune Checkpoint Inhibitor-Induced Pneumonitis: A Multidisciplinary Diagnostic and Therapeutic Challenge. [PDF]

Am J Case Rep
Kaldas M, Shah M, Ivanova V, Alnaimat S, Pashaieva D, Williams R, Radhakrishnan A.   +6 more
europepmc   +1 more source